Patent · US Active

Method of treatment for acute myelogenous leukemia

US8575216B2 · kind B2 · utility

2Cited by
0References
1Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 4, 2010
Grant dateNov 5, 2013
Priority date—
Expiry dateMar 15, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a method of treating acute myelogenous leukemia with TPA along with Dexamethasone and choline magnesium trisalicylate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.